Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,925 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer.
Sriramulu S, Thoidingjam S, Chen WM, Hassan O, Siddiqui F, Brown SL, Movsas B, Green MD, Davis AJ, Speers C, Walker E, Nyati S. Sriramulu S, et al. Among authors: walker e. bioRxiv [Preprint]. 2024 May 10:2024.05.07.592812. doi: 10.1101/2024.05.07.592812. bioRxiv. 2024. Update in: J Exp Clin Cancer Res. 2024 Jun 11;43(1):163. doi: 10.1186/s13046-024-03086-9 PMID: 38766122 Free PMC article. Updated. Preprint.
Revisiting the Defeatist Performance Belief Scale in Adults With Schizophrenia and Youth at Clinical High-Risk for Psychosis: A Comprehensive Psychometric Analysis.
Luther L, Ahmed AO, Grant PM, Granholm E, Gold JM, Williams TF, Pratt D, Holden J, Walker EF, Arnold L, Ellman LM, Mittal VA, Zinbarg R, Silverstein SM, Corlett PR, Powers AR, Woods SW, Waltz JA, Schiffman J, Strauss GP. Luther L, et al. Among authors: walker ef. Schizophr Bull. 2025 Jan 2:sbae220. doi: 10.1093/schbul/sbae220. Online ahead of print. Schizophr Bull. 2025. PMID: 39749462
Structural Convergence and Water-Mediated Substrate Mimicry Enable Broad Neuraminidase Inhibition by Human Antibodies.
Lederhofer J, Borst AJ, Nguyen L, Gillespie RA, Williams CJ, Walker EL, Raab JE, Yap C, Ellis D, Creanga A, Tan HX, Do THT, Ravichandran M, McDermott AB, Sage VL, Andrews SF, Graham BS, Wheatley AK, Reed DS, King NP, Kanekiyo M. Lederhofer J, et al. Among authors: walker el. bioRxiv [Preprint]. 2024 Dec 3:2024.11.27.625426. doi: 10.1101/2024.11.27.625426. bioRxiv. 2024. PMID: 39677750 Free PMC article. Preprint.
Number of macula optical coherence tomography scans needed to detect glaucoma progression.
Mahmoudinezhad G, Moghimi S, Latif K, Brye N, Walker E, Nishida T, Du KH, Gunasegaran G, Wu JH, Liebmann JM, Fazio MA, Girkin CA, Zangwill LM, Weinreb RN. Mahmoudinezhad G, et al. Among authors: walker e. Br J Ophthalmol. 2024 Dec 11:bjo-2023-324916. doi: 10.1136/bjo-2023-324916. Online ahead of print. Br J Ophthalmol. 2024. PMID: 39663002
The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.
Kotwal SS, Perkovic V, Jardine MJ, Kim D, Shah NA, Lin E, Coggan S, Billot L, Vart P, Wheeler DC, de Boer IH, Zhang H, Hou FF, Sugawara Y, Marion J, Lewis RJ, Berry LR, McGlothlin A, Jha V, De Nicola L, Gorriz JL, Heerspink HJL; GKPTN and CAPTIVATE Investigators. Kotwal SS, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2449998. doi: 10.1001/jamanetworkopen.2024.49998. JAMA Netw Open. 2024. PMID: 39661388 Free PMC article.
2,925 results